Thursday, October 15th
Hall A Hall B
08:45-09:00 Welcome Coffee
09:00-12:00 IACH 1: Workshop
12:00-12:30 Lunch Break
12:30-13:00 IACH 2: Awards Session
13:00-14:15 Transplant 1 13:00-14:15 COMydAL 1: AML I
14:15-15:30 Transplant 2 14:15-15:30 COMydAL 2: AML II
15:30-16:45 Industry Symposium 15:30-16:45 Industry Symposium
16:45-17:00 Coffee Break
17:00-18:15 Transplant 3 17:00-18:15 COMydAL 3: CMML, MDS/MPN and others
18:15 Meeting Welcome Reception
Friday, October 16th
Hall A Hall B
08:30-09:45 Transplant 4 08:30-09:45 COMydAL 4
09:45-10:00 Coffee Break
10:00-11:15 Transplant 5 10:00-11:15 COMydAL 5
11:15-12:30 Industry Symposium 11:15-12:30 Industry Symposium
12:30-13:00 Lunch Break
13:00-14:15 COLYM 1: From Biology to Bedside: What Will Really Change Practice? 13:00-14:15 MPNCo&D 1: Redefining disease and risk: are we stratifying patients correctly?
14:15-15:30 Industry Symposium 14:15-15:30 Industry Symposium
15:30-16:45 COLYM 2: Redefining Frontline Therapy: Risk, Response, and Reality 15:30-16:45 MPNCo&D 2: Anemia in myelofibrosis: mechanism-driven therapy or trial-and-error?
16:45-17:00 Coffee Break
17:00-18:15 IACH 3
Saturday, October 17th
Hall A Hall B
08:30-09:45 COLYM 3: Sequencing in Relapsed Lymphoma: Making Sense of Too Many Options 08:30-09:45 MPNCo&D 3: Next-generation targeted therapies: beyond JAK inhibition in MF
09:45-10:00 Coffee Break
10:00-11:15 COLYM 4: Hodgkin Lymphoma: Optimizing Therapy Across Risk Groups 10:00-11:15 MPNCo&D 4: Transplant, disease evolution, and overlap biology
11:15-12:30 Industry Symposium 11:15-12:30 Industry Symposium
12:30-13:00 Lunch Break
13:00-14:15 COLYM 5: Rare, Neglected, and Difficult Lymphomas 13:00-14:15 MPNCo&D 5: New options for Essential Thrombocythemia and Polycythemia Vera — are they needed and when should we use them?
14:15-15:30 IACH 4
15:30-15:45 Coffee Break
15:45-16:15 IACH 5